Global Perspectives

WHO Vaccinates Against Ebola with Merck & Co.'s Experimental Vaccine

May 30, 2018

World Health Organization’s Ebola ring vaccination uses Merck & Co.’s investigational rVSV-ZEBOV vaccine to protect high-risk communities in the Democratic Republic of the Congo from Ebola.

China’s Pharma Growth Potential to Drive Attendance at CPhI China

May 17, 2018

Internationalization and regulatory reform are driving growth and investment China.

Forecasting Bio/Pharma in 2018

January 02, 2018

Brexit-related challenges cast shadows on prospects for the European bio/pharma market in 2018, but optimism may let some sun shine through.

Novartis, ASCP, and ACS Partner for African Cancer Initiative

November 16, 2017

The entities announced that they will partner to improve access to cancer treatments and diagnostics in Ethiopia, Uganda, and Tanzania.

FDA to Recognize Inspections from EU Drug Authorities

October 31, 2017

A mutual recognition agreement to accept inspection data from eight EU regulatory authorities may reduce inspection burdens at global drug facilities.

Storm Impact on Drug Supply

October 05, 2017

FDA and manufacturers strive to prevent drug shortages from Hurricane Maria.

Pharma’s Role in Puerto Rico’s Future

October 02, 2017

Reeling from financial and tropical storms, Puerto Rico needs stable industry for recovery.

WHO Launches Biosimilar Pilot Program

May 05, 2017

The program aims to make biosimilars for the treatment of cancer more widely available in middle- and low-income countries.

Staffing for China’s Rapidly Growing Biomanufacturing Industry

April 02, 2017

New study shows China biopharma companies face staffing shortages.

A New Location for EMA?

February 10, 2017

Pharmaceutical Technology spoke with Tommy Fanning, head of biopharmaceuticals for IDA Ireland, to get a perspective on how Brexit may affect the pharmaceutical industry.